| Patricio Rosa, MD | |
|
1010 Woodland Dr, Elizabethtown, KY 42701-3706 | |
| (270) 706-5171 | |
| (270) 706-5738 |
| Full Name | Patricio Rosa |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 35 Years |
| Location | 1010 Woodland Dr, Elizabethtown, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629055868 | NPI | - | NPPES |
| 57913 | Other | FL | BCBS |
| 267826800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | ME111938 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
With drug prices for cancer and many other conditions soaring to new highs amid questions about their true value to patients, the Institute for Clinical and Economic Review today launched a program to transform the way new drugs are evaluated and priced in the United States.
February 14th is National Donor Day. To celebrate, Gift of Hope Organ & Tissue Donor Network announced a record number of lives saved by helping 334 donors and their families donate 1,020 organs to patients waiting for a transplant, giving them a second chance at life last year.
Ligand Pharmaceuticals Incorporated announced today that it has initiated a pivotal trial of Captisol-enabled, propylene glycol-free (PG-free) high-dose melphalan as a conditioning treatment prior to autologous transplant for patients with multiple myeloma.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
› Verified 9 days ago
| Entity Name | Ephraim Mcdowell Health Resource Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487708533 PECOS PAC ID: 7517876956 Enrollment ID: O20031218000776 |
News Archive
With drug prices for cancer and many other conditions soaring to new highs amid questions about their true value to patients, the Institute for Clinical and Economic Review today launched a program to transform the way new drugs are evaluated and priced in the United States.
February 14th is National Donor Day. To celebrate, Gift of Hope Organ & Tissue Donor Network announced a record number of lives saved by helping 334 donors and their families donate 1,020 organs to patients waiting for a transplant, giving them a second chance at life last year.
Ligand Pharmaceuticals Incorporated announced today that it has initiated a pivotal trial of Captisol-enabled, propylene glycol-free (PG-free) high-dose melphalan as a conditioning treatment prior to autologous transplant for patients with multiple myeloma.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
› Verified 9 days ago
| Entity Name | Hardin Professional Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306894704 PECOS PAC ID: 9739191628 Enrollment ID: O20060614000061 |
News Archive
With drug prices for cancer and many other conditions soaring to new highs amid questions about their true value to patients, the Institute for Clinical and Economic Review today launched a program to transform the way new drugs are evaluated and priced in the United States.
February 14th is National Donor Day. To celebrate, Gift of Hope Organ & Tissue Donor Network announced a record number of lives saved by helping 334 donors and their families donate 1,020 organs to patients waiting for a transplant, giving them a second chance at life last year.
Ligand Pharmaceuticals Incorporated announced today that it has initiated a pivotal trial of Captisol-enabled, propylene glycol-free (PG-free) high-dose melphalan as a conditioning treatment prior to autologous transplant for patients with multiple myeloma.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
› Verified 9 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
With drug prices for cancer and many other conditions soaring to new highs amid questions about their true value to patients, the Institute for Clinical and Economic Review today launched a program to transform the way new drugs are evaluated and priced in the United States.
February 14th is National Donor Day. To celebrate, Gift of Hope Organ & Tissue Donor Network announced a record number of lives saved by helping 334 donors and their families donate 1,020 organs to patients waiting for a transplant, giving them a second chance at life last year.
Ligand Pharmaceuticals Incorporated announced today that it has initiated a pivotal trial of Captisol-enabled, propylene glycol-free (PG-free) high-dose melphalan as a conditioning treatment prior to autologous transplant for patients with multiple myeloma.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricio Rosa, MD 1665 Quirks Run Rd, Danville, KY 40422-8830 Ph: (859) 236-4269 | Patricio Rosa, MD 1010 Woodland Dr, Elizabethtown, KY 42701-3706 Ph: (270) 706-5171 |
News Archive
With drug prices for cancer and many other conditions soaring to new highs amid questions about their true value to patients, the Institute for Clinical and Economic Review today launched a program to transform the way new drugs are evaluated and priced in the United States.
February 14th is National Donor Day. To celebrate, Gift of Hope Organ & Tissue Donor Network announced a record number of lives saved by helping 334 donors and their families donate 1,020 organs to patients waiting for a transplant, giving them a second chance at life last year.
Ligand Pharmaceuticals Incorporated announced today that it has initiated a pivotal trial of Captisol-enabled, propylene glycol-free (PG-free) high-dose melphalan as a conditioning treatment prior to autologous transplant for patients with multiple myeloma.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
› Verified 9 days ago
Dr. John Morrell Pendleton, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Ring Rd, Hardin Memorial Surgical Specialists, Elizabethtown, KY 42701 Phone: 270-769-5551 | |
Marshall Johnson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Ring Rd, Elizabethtown, KY 42701 Phone: 270-769-5551 Fax: 270-765-3919 | |
Thomas Taylor, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1700 Ring Rd, Elizabethtown, KY 42701 Phone: 270-769-5551 Fax: 270-765-3919 | |
Todd Y. Chadwell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Ring Rd, Elizabethtown, KY 42701 Phone: 270-769-5551 Fax: 270-765-3919 | |
Karen J Brunkhorst, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Ring Rd, Elizabethtown, KY 42701 Phone: 270-769-5551 Fax: 270-765-3919 | |
Robert E. Robbins, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1107 Crown Pointe Dr, Suite C, Elizabethtown, KY 42701 Phone: 270-982-1200 Fax: 270-234-1952 | |
Jeffrey Austin, MD Surgery Medicare: Medicare Enrolled Practice Location: 913 N Dixie Ave, Elizabethtown, KY 42701 Phone: 270-769-5551 |